Showing posts with label drug prices. Show all posts
Showing posts with label drug prices. Show all posts

Monday, August 17, 2026

Trump shows off article on lower drug prices that says Biden deserves credit, not him

“The Inflation Reduction Act was a signature accomplishment of former president Joe Biden, a sprawling measure enacted in 2022 that aimed to lower prescription drug prices by requiring Medicare, the federal health program for the elderly, to begin negotiating the prices it pays drugmakers for an array of popular and costly prescription drugs,” the Post’s report noted. “The first price reductions took effect at the beginning of this year.”…

 https://www.theguardian.com/us-news/2026/aug/15/trump-washington-post-drug-prices


 

Friday, June 12, 2026

Revlimid: The $0.25 Cancer Pill That Sold for Nearly $1,000 — ProPublica

Armstrong: And I just happened to find it. There was a lawsuit that a, um, generic drug company filed against Celgene, and buried in thousands of pages was an excerpt of a deposition of Celgene’s head of manufacturing. And a lawyer asked him flat out, “What does it cost to make this drug?” And he said 25 cents. And I remember the moment I saw that, I, I knew that it was a big markup involved, but when he said that the cost was 25 cents a pill, and it had always been 25 cents a pill, and it’s still 25 cents a pill, I was just really floored by that... 

One of the former sales officials said that internally they thought they could charge whatever they wanted, that cancer patients will pay whatever price the company put on this pill. So there were, from the time Revlimid was approved by the FDA in 2005 to current day, 26 price hikes.  So it was a bluff that was called. And for Celgene, it was an incredibly lucrative bet that they made...

 https://www.propublica.org/podcast/revlimid-cancer-drugs-fda-healthcare 


Wednesday, May 20, 2026

President says he’s adding ‘over 600’ prescription drugs to TrumpRx site

Despite the rollout and expansion of TrumpRx, some experts argue the platform is “not a solution” for many patients. 

Speaking to the Guardian earlier this year, Sean Sullivan, a professor of health economics and policy and former dean of pharmacy at the University of Washington, said: “Consumers can probably get a cheaper version of these medicines through insurance and their pharmacies, or via cash pay services like Cost Plus Drugs than by the deals offered through TrumpRx.”…

https://www.theguardian.com/us-news/2026/may/18/trumprx-site-prescription-drugs


 

Tuesday, February 17, 2026

Trump’s Latest HEALTH SCAM is FINALLY EXPOSED

Dr. Haydée Brown and Dr. Sonya Sloan break down what TrumpRx does, who it helps, and why many health economists say it does not address the root causes of high drug costs. We examine the limited list of medications, comparisons to existing discount programs like GoodRx, the spotlight on GLP-1 weight-loss drugs and fertility medications, and the larger structural questions about congressional authority, executive power, and real policy reform.

https://www.youtube.com/watch?v=ilRP8NYnlGU

Friday, August 1, 2025

Wednesday, May 14, 2025

Trump's drug price plan: Why it may not amount to much change

"We don't completely discount the possibility that the EO could eventually lead to some one-off deals, but the order itself is so vague that it's difficult to predict the exact impact it may have," Capital Alpha's Kim Monk wrote in a note...

Sunday, February 23, 2025

Zolgensma Creation Story Reveals Truths About Drug Pricing — ProPublica

Reporting Highlights

  • A Record Price: The gene therapy Zolgensma helped children born with a fatal disease, spinal muscular atrophy, grow up to run and play. But the cost was stunning: $2 million per dose.
  • Cashing In: While taxpayers and small charities funded the drug's early development, executives, venture-capital backers and a pharma giant have reaped the profits.
  • Priced Out: The drug's cost adds to the nation's ballooning bill for prescription drugs and puts Zolgensma out of reach for kids in many low- and middle-income countries.


Tuesday, January 28, 2025

RFK Jr. says he’s open to seizing drug patents - POLITICO

The approach — long supported by progressive Democrats and only tentatively by former President Joe Biden — would use executive authorities to take certain drug patents developed using taxpayer money and license them to other manufacturers that might make and sell them for less. Advocates for the policy say it would allow new levels of competition for some of the most expensive prescription drugs, which are now protected by patents...

https://www.politico.com/news/2025/01/27/rfk-jr-health-drug-pricing-00200830


 








Click Older Posts above to see more.